Načítá se...
Body mass index adjusted prostate-specific antigen and its application for prostate cancer screening
OBJECTIVES: The Prostate Cancer Prevention Trial (PCPT) prostate cancer risk calculator was developed to aid physicians in counseling men for consideration of prostate biopsy based on prostate-specific antigen (PSA) and other clinical risk factors. This study investigated the role of body mass index...
Uloženo v:
| Hlavní autoři: | , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2010
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2975830/ https://ncbi.nlm.nih.gov/pubmed/20739049 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.urology.2010.04.060 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|